Patents by Inventor Li-Hsien Wang
Li-Hsien Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240161818Abstract: The invention provides a layout pattern of static random access memory (SRAM), which at least comprises a plurality of gate structures located on a substrate and spanning the plurality of fin structures to form a plurality of transistors distributed on the substrate, wherein the plurality of transistors comprise two pull-up transistors (PU), two pull-down transistors (PD) to form a latch circuit, and two access transistors (PG) connected to the latch circuit. In each SRAM memory cell, the fin structure included in the pull-up transistor (PU) is defined as a PU fin structure, the fin structure included in the pull-down transistor (PD) is defined as a PD fin structure, and the fin structure included in the access transistor (PG) is defined as a PG fin structure, wherein a width of the PD fin structure is wider than a width of the PG fin structure.Type: ApplicationFiled: November 30, 2022Publication date: May 16, 2024Applicant: UNITED MICROELECTRONICS CORP.Inventors: Chun-Hsien Huang, Yu-Tse Kuo, Shu-Ru Wang, Li-Ping Huang, Yu-Fang Chen, Chun-Yen Tseng, Tzu-Feng Chang, Chun-Chieh Chang
-
Patent number: 11963521Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R? gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human C IL-4R? locus.Type: GrantFiled: August 5, 2021Date of Patent: April 23, 2024Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Publication number: 20240096630Abstract: Disclosed is a semiconductor fabrication method. The method includes forming a gate stack in an area previously occupied by a dummy gate structure; forming a first metal cap layer over the gate stack; forming a first dielectric cap layer over the first metal cap layer; selectively removing a portion of the gate stack and the first metal cap layer while leaving a sidewall portion of the first metal cap layer that extends along a sidewall of the first dielectric cap layer; forming a second metal cap layer over the gate stack and the first metal cap layer wherein a sidewall portion of the second metal cap layer extends further along a sidewall of the first dielectric cap layer; forming a second dielectric cap layer over the second metal cap layer; and flattening a top layer of the first dielectric cap layer and the second dielectric cap layer using planarization operations.Type: ApplicationFiled: January 12, 2023Publication date: March 21, 2024Applicant: Taiwan Semiconductor Manufacturing Company, Ltd.Inventors: Li-Wei Yin, Tzu-Wen Pan, Yu-Hsien Lin, Yu-Shih Wang, Jih-Sheng Yang, Shih-Chieh Chao, Yih-Ann Lin, Ryan Chia-Jen Chen
-
Publication number: 20240072170Abstract: A semiconductor device is disclosed. The semiconductor device includes a semiconductor fin. The semiconductor device includes first spacers over the semiconductor fin. The semiconductor device includes a metal gate structure, over the semiconductor fin, that is sandwiched at least by the first spacers. The semiconductor device includes a gate electrode contacting the metal gate structure. An interface between the metal gate structure and the gate electrode has its side portions extending toward the semiconductor fin with a first distance and a central portion extending toward the semiconductor fin with a second distance, the first distance being substantially less than the second distance.Type: ApplicationFiled: August 24, 2022Publication date: February 29, 2024Applicant: Taiwan Semiconductor Manufacturing Company, Ltd.Inventors: Li-Wei Yin, Tzu-Wen Pan, Yu-Hsien Lin, Yu-Shih Wang, Yih-Ann Lin, Chia Ming Liang, Ryan Chia-Jen CHEN
-
Patent number: 11915755Abstract: A layout of a semiconductor memory device includes a substrate and a ternary content addressable memory (TCAM). The TCAM is disposed on the substrate and includes a plurality of TCAM bit cells, where at least two of the TCAM bit cells are mirror-symmetrical along an axis of symmetry, and each of the TCAM bit cells includes two storage units electrically connected to two word lines respectively, and a logic circuit electrically connected to the storage units. The logic circuit includes two first reading transistors, and two second reading transistors, where each of the second reading transistors includes a gate and source and drain regions, the source and drain regions of the second reading transistors are electrically connected to two matching lines and the first reading transistors, respectively, where the word lines are disposed parallel to and between the matching lines.Type: GrantFiled: January 20, 2022Date of Patent: February 27, 2024Assignee: UNITED MICROELECTRONICS CORP.Inventors: Chun-Yen Tseng, Yu-Tse Kuo, Shu-Ru Wang, Chun-Hsien Huang, Hsin-Chih Yu, Meng-Ping Chuang, Li-Ping Huang, Yu-Fang Chen
-
Publication number: 20230027494Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R? gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human C IL-4R? locus.Type: ApplicationFiled: August 30, 2022Publication date: January 26, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Publication number: 20220053742Abstract: Mice that comprise a replacement of endogenous mouse IL-6 and/or IL-6 receptor genes are described, and methods for making and using the mice. Mice comprising a replacement at an endogenous IL-6R? locus of mouse ectodomain-encoding sequence with human ectodomain-encoding sequence is provided. Mice comprising a human IL-6 gene under control of mouse IL-6 regulatory elements is also provided, including mice that have a replacement of mouse IL-6-encoding sequence with human IL-6-encoding sequence at an endogenous mouse IL-6 locus.Type: ApplicationFiled: July 26, 2021Publication date: February 24, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Li-Hsien Wang, Anthony T. Dore, Jr., Sean Stevens, Andrew J. Murphy
-
Publication number: 20210368753Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R? gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human C IL-4R? locus.Type: ApplicationFiled: August 5, 2021Publication date: December 2, 2021Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Patent number: 11109578Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R? gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human C IL-4R? locus.Type: GrantFiled: October 7, 2019Date of Patent: September 7, 2021Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Patent number: 11102962Abstract: Mice that comprise a replacement of endogenous mouse IL-6 and/or IL-6 receptor genes are described, and methods for making and using the mice. Mice comprising a replacement at an endogenous IL-6R? locus of mouse ectodomain-encoding sequence with human ectodomain-encoding sequence is provided. Mice comprising a human IL-6 gene under control of mouse IL-6 regulatory elements is also provided, including mice that have a replacement of mouse IL-6-encoding sequence with human IL-6-encoding sequence at an endogenous mouse IL-6 locus.Type: GrantFiled: July 3, 2019Date of Patent: August 31, 2021Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Li-Hsien Wang, Anthony T. Dore, Jr., Sean Stevens, Andrew J. Murphy
-
Publication number: 20210259257Abstract: The present invention provides a soft material forming apparatus, which comprises a forming mold assembly and a detaching assembly. The forming mold assembly comprises a first roller and a second roller, for extruding a product. There is a specific interval between the detaching assembly and the first roller. The product comprises a release portion which is the earliest part of the product that contacts the detaching assembly. With the specific interval and the rotatability of the detaching assembly, the product can be released from the forming mold assembly.Type: ApplicationFiled: May 19, 2020Publication date: August 26, 2021Inventors: LI-HSIEN WANG, CHIEN YUAN, YOU-CHEN TSAI
-
Patent number: 10966433Abstract: A stuffing filling and gas charging system of a dough food product machine is arranged between a stuffing feeding unit and a dough feeding unit of the dough food product machine and includes a stuffing conveyance pipe, and a shaft sleeve, a dough driving rod, and a screw rod support enclosure sleeved over the stuffing conveyance pipe. A first passage is formed between the shaft sleeve and the stuffing conveyance pipe; a second passage is formed between the dough driving rod and the stuffing conveyance pipe; and a third passage is formed between the screw rod support enclosure and the stuffing conveyance pipe. The passages are in communication with each other and are connected to a gas supply unit, so that air flow is introduced into a dough skin during the dough skin being shaped to prevent the dough skin from wrinkling and collapsing before being properly shaped.Type: GrantFiled: May 24, 2019Date of Patent: April 6, 2021Assignee: ANKO FOOD MACHINE CO., LTD.Inventor: Li-Hsien Wang
-
Publication number: 20200367511Abstract: A stuffing filling and gas charging system of a dough food product machine is arranged between a stuffing feeding unit and a dough feeding unit of the dough food product machine and includes a stuffing conveyance pipe, and a shaft sleeve, a dough driving rod, and a screw rod support enclosure sleeved over the stuffing conveyance pipe. A first passage is formed between the shaft sleeve and the stuffing conveyance pipe; a second passage is formed between the dough driving rod and the stuffing conveyance pipe; and a third passage is formed between the screw rod support enclosure and the stuffing conveyance pipe. The passages are in communication with each other and are connected to a gas supply unit, so that air flow is introduced into a dough skin during the dough skin being shaped to prevent the dough skin from wrinkling and collapsing before being properly shaped.Type: ApplicationFiled: May 24, 2019Publication date: November 26, 2020Inventor: Li-Hsien Wang
-
Patent number: 10588298Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R?, gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human CIL-4R? locus.Type: GrantFiled: July 14, 2017Date of Patent: March 17, 2020Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Publication number: 20200022344Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R? gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human C IL-4R? locus.Type: ApplicationFiled: October 7, 2019Publication date: January 23, 2020Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Publication number: 20200008407Abstract: Mice that comprise a replacement of endogenous mouse IL-6 and/or IL-6 receptor genes are described, and methods for making and using the mice. Mice comprising a replacement at an endogenous IL-6R? locus of mouse ectodomain-encoding sequence with human ectodomain-encoding sequence is provided. Mice comprising a human IL-6 gene under control of mouse IL-6 regulatory elements is also provided, including mice that have a replacement of mouse IL-6-encoding sequence with human IL-6-encoding sequence at an endogenous mouse IL-6 locus.Type: ApplicationFiled: July 3, 2019Publication date: January 9, 2020Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Li-Hsien Wang, Anthony T. Dore, Jr., Sean Stevens, Andrew J. Murphy
-
Patent number: 10477842Abstract: Non-human animals comprising a human or humanized IL-4 and/or IL-4R? nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4R? gene with a human IL-4 gene and/or IL-4R? gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4R? gene under control of non-human IL-4R? regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4R?-encoding sequence with human or humanized IL-4R?-encoding sequence at an endogenous non-human C IL-4R? locus.Type: GrantFiled: September 15, 2017Date of Patent: November 19, 2019Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Li-Hsien Wang, Yingzi Xue, Andrew J. Murphy, Sean Stevens
-
Patent number: 10433528Abstract: Mice that comprise a replacement of endogenous mouse IL-6 and/or IL-6 receptor genes are described, and methods for making and using the mice. Mice comprising a replacement at an endogenous IL-6R? locus of mouse ectodomain-encoding sequence with human ectodomain-encoding sequence is provided. Mice comprising a human IL-6 gene under control of mouse IL-6 regulatory elements is also provided, including mice that have a replacement of mouse IL-6-encoding sequence with human IL-6-encoding sequence at an endogenous mouse IL-6 locus.Type: GrantFiled: June 6, 2018Date of Patent: October 8, 2019Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Li-Hsien Wang, Anthony T. Dore, Jr., Sean Stevens, Andrew J. Murphy
-
Patent number: 10390537Abstract: A dough preparation machine includes a power unit, which drives, through rotational speed mechanism, a helical screw shaft that extends into a dough chamber so that the dough is compressed and pushed through rotation of the helical screw shaft to be discharged out of a jet nozzle mounted to the dough chamber. The dough chamber is provided, at a location above the helical screw shaft, with an auxiliary dough driver, which includes two movable blades that are opposite to each other and are selectively extendable outward and retractable inward. When one of the movable blades passes through a circular sidewall of dough chamber, it is pressed by the sidewall to get retracted inwardly and at the same time causing another one of the movable blades to extend outward to knead and poke dough. This process is cyclically repeated to efficiently knead the dough and prevent attachment of the dough.Type: GrantFiled: November 16, 2017Date of Patent: August 27, 2019Assignee: ANKO FOOD MACHINE CO., LTD.Inventor: Li-Hsien Wang
-
Publication number: 20190142018Abstract: A dough preparation machine includes a power unit, which drives, through rotational speed mechanism, a helical screw shaft that extends into a dough chamber so that the dough is compressed and pushed through rotation of the helical screw shaft to be discharged out of a jet nozzle mounted to the dough chamber. The dough chamber is provided, at a location above the helical screw shaft, with an auxiliary dough driver, which includes two movable blades that are opposite to each other and are selectively extendable outward and retractable inward. When one of the movable blades passes through a circular sidewall of dough chamber, it is pressed by the sidewall to get retracted inwardly and at the same time causing another one of the movable blades to extend outward to knead and poke dough. This process is cyclically repeated to efficiently knead the dough and prevent attachment of the dough.Type: ApplicationFiled: November 16, 2017Publication date: May 16, 2019Inventor: Li-Hsien Wang